Linnea Ruth Freeman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Linnea Ruth Freeman has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Anju Saxena
Affiliation Neurosciences, Furman University, Greenville, South Carolina, United States of America
2 shared publicationsEmma O. Bondy
Affiliation Neurosciences, Furman University, Greenville, South Carolina, United States of America
2 shared publicationsGrace Welch
Department of Biology, Furman University, Greenville, USA
2 shared publicationsJagroop Singh
Affiliation Department of Biology, Furman University, Greenville, South Carolina, United States of America
2 shared publicationsJuhi Saxena
Affiliation Neurosciences, Furman University, Greenville, South Carolina, United States of America
2 shared publicationsLindsay DiBerardo
Lake Erie College of Osteopathic Medicine, Bradenton, USA
2 shared publications
Latest Publications
- Open Access
- 6 September 2026
- Published by Springer Nature in Biology of Sex Differences
Sex differences in hedonic feeding and characterizing the effects of antibiotic-induced microbiome disruption
Background: Obesity continues to be a public health issue in our country. Additionally, there continues to be a higher incidence of severe obesity for women compared to men. Among the proposed causes of obesity is increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor. Emerging evidence shows that the gut microbiome impacts feeding behavior and studies have shown that individuals with obesity exhibit an altered gut microbiome. Methods: Here, we used a novel behavioral economics (BE) approach to evaluate hedonic feeding in male and female Sprague-Dawley rats for a high-fat palatable (HFP) reward pellet, before and after antibiotic administration. This BE approach is a de-escalating fixed ratio operant task designed to evaluate a reward’s value and measure how much effort the subject is willing to expend to earn that reward. Using this approach, we measured demand elasticity (α), the rate at which demand falls when the price or effort required increases, and demand at null cost (Q 0 ), a prediction of consumption at null effort extrapolated from the animals’ consumption at low price. Results: We determined a higher demand at null cost (Q 0 ) for the HFP reward pellet for females compared to males, as we have observed previously. Next, we administered an antibiotic cocktail in the drinking water to disrupt the gut microbiome and investigate a role of the gut microbiome in hedonic feeding. Female rats administered antibiotics continued to have a higher demand at null cost compared to male control rats, but no statistically significant differences were determined between male and female rats administered antibiotics. We characterized the fecal microbiome genus-level composition and short chain fatty acid (SCFA) levels before and after antibiotic administration. We also characterized serum SCFA and bile acid levels at the end of the study. Conclusions: We did not determine a significant effect of antibiotics on hedonic feeding, despite disruption to the fecal microbiome. Additionally, we did not observe striking baseline sex differences in fecal microbiome diversity and composition. This brings to question whether the gut microbiome contributes to sex differences in hedonic feeding. More research will be necessary for network factors such as microbiome – bile acid effects on feeding that exhibit sex differences.
- 6 September 2026
- Published by Springer Nature in Biology of Sex Differences
Open AccessSex differences in hedonic feeding and characterizing the effects of antibiotic-induced microbiome disruption
Background: Obesity continues to be a public health issue in our country. Additionally, there continues to be a higher incidence of severe obesity for women compared to men. Among the proposed causes of obesity is increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor. Emerging evidence shows that the gut microbiome impacts feeding behavior and studies have shown that individuals with obesity exhibit an altered gut microbiome. Methods: Here, we used a novel behavioral economics (BE) approach to evaluate hedonic feeding in male and female Sprague-Dawley rats for a high-fat palatable (HFP) reward pellet, before and after antibiotic administration. This BE approach is a de-escalating fixed ratio operant task designed to evaluate a reward’s value and measure how much effort the subject is willing to expend to earn that reward. Using this approach, we measured demand elasticity (α), the rate at which demand falls when the price or effort required increases, and demand at null cost (Q 0 ), a prediction of consumption at null effort extrapolated from the animals’ consumption at low price. Results: We determined a higher demand at null cost (Q 0 ) for the HFP reward pellet for females compared to males, as we have observed previously. Next, we administered an antibiotic cocktail in the drinking water to disrupt the gut microbiome and investigate a role of the gut microbiome in hedonic feeding. Female rats administered antibiotics continued to have a higher demand at null cost compared to male control rats, but no statistically significant differences were determined between male and female rats administered antibiotics. We characterized the fecal microbiome genus-level composition and short chain fatty acid (SCFA) levels before and after antibiotic administration. We also characterized serum SCFA and bile acid levels at the end of the study. Conclusions: We did not determine a significant effect of antibiotics on hedonic feeding, despite disruption to the fecal microbiome. Additionally, we did not observe striking baseline sex differences in fecal microbiome diversity and composition. This brings to question whether the gut microbiome contributes to sex differences in hedonic feeding. More research will be necessary for network factors such as microbiome – bile acid effects on feeding that exhibit sex differences.
- 25 February 2025
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 126, 313-314
Interactions between sex hormones and the gut microbiome
- 25 February 2025
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 126, 313-314
Interactions between sex hormones and the gut microbiome
- Top Cited PapersOpen Access
- 10 January 2024
- Published by Springer Nature in Biology of Sex Differences
- Vol. 15  (1) , 1-15
Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome
Background: Recent decades have seen an exponential rise in global obesity prevalence, with rates nearly doubling in a span of 40 years. A comprehensive knowledge base regarding the systemic effects of obesity is required to create new preventative and therapeutic agents effective at combating the current obesity epidemic. Previous studies of diet-induced obesity utilizing mouse models have demonstrated a difference in bodyweight gain by sex. In such studies, female mice gained significantly less weight than male mice when given the same high fat (HF) diet, indicating a resistance to diet-induced obesity. Research has also shown sex differences in gut microbiome composition between males and females, indicated to be in part a result of sex hormones. Understanding metabolic differences between sexes could assist in the development of new measures for obesity prevention and treatment. This study aimed to characterize sex differences in weight gain, plasma lipid profiles, fecal microbiota composition, and fecal short chain fatty acid levels. We hypothesized a role for the gut microbiome in these sex differences that would be normalized following microbiome depletion. Methods: A mouse model was used to study these effects. Mice were divided into treatment groups by sex, diet, and presence/absence of an antibiotic cocktail to deplete genera in the gut microbiome. We hypothesized that sex differences would be present both in bodyweight gain and systemic measures of obesity, including hormone and circulating free fatty acid levels. Results: We determined statistically significant differences for sex and/or treatment for the outcome measures. We confirm previous findings in which male mice gained significantly more weight than female mice fed the same high fat diet. However, sex differences persisted following antibiotic administration for microbiome depletion. Conclusions: We conclude that sex differences in the gut microbiome may contribute to sex differences in obesity, but they do not explain all of the differences.
- 10 January 2024
- Published by Springer Nature in Biology of Sex Differences
- Vol. 15  (1) , 1-15
Top Cited PapersOpen AccessSex differences in a mouse model of diet-induced obesity: the role of the gut microbiome
Background: Recent decades have seen an exponential rise in global obesity prevalence, with rates nearly doubling in a span of 40 years. A comprehensive knowledge base regarding the systemic effects of obesity is required to create new preventative and therapeutic agents effective at combating the current obesity epidemic. Previous studies of diet-induced obesity utilizing mouse models have demonstrated a difference in bodyweight gain by sex. In such studies, female mice gained significantly less weight than male mice when given the same high fat (HF) diet, indicating a resistance to diet-induced obesity. Research has also shown sex differences in gut microbiome composition between males and females, indicated to be in part a result of sex hormones. Understanding metabolic differences between sexes could assist in the development of new measures for obesity prevention and treatment. This study aimed to characterize sex differences in weight gain, plasma lipid profiles, fecal microbiota composition, and fecal short chain fatty acid levels. We hypothesized a role for the gut microbiome in these sex differences that would be normalized following microbiome depletion. Methods: A mouse model was used to study these effects. Mice were divided into treatment groups by sex, diet, and presence/absence of an antibiotic cocktail to deplete genera in the gut microbiome. We hypothesized that sex differences would be present both in bodyweight gain and systemic measures of obesity, including hormone and circulating free fatty acid levels. Results: We determined statistically significant differences for sex and/or treatment for the outcome measures. We confirm previous findings in which male mice gained significantly more weight than female mice fed the same high fat diet. However, sex differences persisted following antibiotic administration for microbiome depletion. Conclusions: We conclude that sex differences in the gut microbiome may contribute to sex differences in obesity, but they do not explain all of the differences.
- Open Access
- 1 November 2023
- Published by Springer Nature in Research Square
Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome
Background:Recent decades have seen an exponential rise in global obesity prevalence, with rates nearly doubling in a span of forty years. A comprehensive knowledge base regarding the systemic effects of obesity is required to create new preventative and therapeutic agents effective at combating the current obesity epidemic. Previous studies of diet-induced obesity utilizing mouse models have demonstrated a difference in bodyweight gain by sex. In such studies, female mice gained significantly less weight than male mice when given the same high fat (HF) diet, indicating a resistance to diet-induced obesity. Research has also shown sex differences in gut microbiome composition between males and females, indicated to be in part a result of sex hormones. Understanding metabolic differences between sexes could assist in the development of new measures for obesity prevention and treatment. This study aimed to characterize sex differences in weight gain, plasma lipid profiles, fecal microbiota composition, and fecal short chain fatty acid levels. We hypothesized a role for the gut microbiome in these sex differences that would be normalized following microbiome depletion. Methods:A mouse model was used to study these effects. Mice were divided into treatment groups by sex, diet, and presence/absence of an antibiotic cocktail to deplete genera in the gut microbiome. We hypothesized that sex differences would be present both in bodyweight gain and systemic measures of obesity, including hormone and circulating free fatty acid levels. Results:We determined statistically significant differences for sex and/or treatment for the outcome measures. We confirm previous findings in which male mice gained significantly more weight than female mice fed the same high fat diet. However, sex differences persisted following antibiotic administration for microbiome depletion. Conclusions:We conclude that sex differences in the gut microbiome may contribute to sex differences in obesity, but they do not explain all of the differences.
- 1 November 2023
- Published by Springer Nature in Research Square
Open AccessSex differences in a mouse model of diet-induced obesity: the role of the gut microbiome
Background:Recent decades have seen an exponential rise in global obesity prevalence, with rates nearly doubling in a span of forty years. A comprehensive knowledge base regarding the systemic effects of obesity is required to create new preventative and therapeutic agents effective at combating the current obesity epidemic. Previous studies of diet-induced obesity utilizing mouse models have demonstrated a difference in bodyweight gain by sex. In such studies, female mice gained significantly less weight than male mice when given the same high fat (HF) diet, indicating a resistance to diet-induced obesity. Research has also shown sex differences in gut microbiome composition between males and females, indicated to be in part a result of sex hormones. Understanding metabolic differences between sexes could assist in the development of new measures for obesity prevention and treatment. This study aimed to characterize sex differences in weight gain, plasma lipid profiles, fecal microbiota composition, and fecal short chain fatty acid levels. We hypothesized a role for the gut microbiome in these sex differences that would be normalized following microbiome depletion. Methods:A mouse model was used to study these effects. Mice were divided into treatment groups by sex, diet, and presence/absence of an antibiotic cocktail to deplete genera in the gut microbiome. We hypothesized that sex differences would be present both in bodyweight gain and systemic measures of obesity, including hormone and circulating free fatty acid levels. Results:We determined statistically significant differences for sex and/or treatment for the outcome measures. We confirm previous findings in which male mice gained significantly more weight than female mice fed the same high fat diet. However, sex differences persisted following antibiotic administration for microbiome depletion. Conclusions:We conclude that sex differences in the gut microbiome may contribute to sex differences in obesity, but they do not explain all of the differences.
- Open Access
- 6 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17  (4) , e0265850
Sex differences in the fecal microbiome and hippocampal glial morphology following diet and antibiotic treatment
Rising obesity rates have become a major public health concern within the United States. Understanding the systemic and neural effects of obesity is crucial in designing preventive and therapeutic measures. In previous studies, administration of a high fat diet has induced significant weight gain for mouse models of obesity. Interestingly, sex differences in high-fat diet-induced weight gain have been observed, with female mice gaining significantly less weight compared to male mice on the same high-fat diet. It has also been observed that consumption of a high-fat diet can increase neurogliosis, but the mechanism by which this occurs is still not fully understood. Recent research has suggested that the gut microbiome may mediate diet-induced glial activation. The current study aimed to (1) analyze changes to the gut microbiome following consumption of a high fat (HF) diet as well as antibiotic treatment, (2) evaluate hippocampal microgliosis and astrogliosis, and (3) identify sex differences within these responses. We administered a low fat (Research Diets D12450 K) or high fat diet (Research Diets D12451) to male and female C57Bl/6 mice for sixteen weeks. Mice received an antibiotic cocktail containing 0.5g/L of vancomycin, 1.0 g/L ampicillin, 1.0 g/L neomycin, and 1.0 g/L metronidazole in their drinking water during the last six weeks of the study and were compared to control mice receiving normal drinking water throughout the study. We observed a significant reduction in gut microbiome diversity for groups that received the antibiotic cocktail, as determined by Illumina next-generation sequencing. Male mice fed the HF diet (± antibiotics) had significantly greater body weights compared to all other groups. And, female mice fed the low fat (LF) diet and administered antibiotics revealed significantly decreased microgliosis and astrogliosis in the hippocampus compared to LF-fed females without antibiotics. Interestingly, male mice fed the LF diet and administered antibiotics revealed significantly increased microgliosis, but decreased astrogliosis, compared to LF-fed males without antibiotics. The observed sex differences in LF-fed mice given antibiotics brings forward questions about sex differences in nutrient metabolism, gut microbiome composition, and response to antibiotics.
- 6 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17  (4) , e0265850
Open AccessSex differences in the fecal microbiome and hippocampal glial morphology following diet and antibiotic treatment
Rising obesity rates have become a major public health concern within the United States. Understanding the systemic and neural effects of obesity is crucial in designing preventive and therapeutic measures. In previous studies, administration of a high fat diet has induced significant weight gain for mouse models of obesity. Interestingly, sex differences in high-fat diet-induced weight gain have been observed, with female mice gaining significantly less weight compared to male mice on the same high-fat diet. It has also been observed that consumption of a high-fat diet can increase neurogliosis, but the mechanism by which this occurs is still not fully understood. Recent research has suggested that the gut microbiome may mediate diet-induced glial activation. The current study aimed to (1) analyze changes to the gut microbiome following consumption of a high fat (HF) diet as well as antibiotic treatment, (2) evaluate hippocampal microgliosis and astrogliosis, and (3) identify sex differences within these responses. We administered a low fat (Research Diets D12450 K) or high fat diet (Research Diets D12451) to male and female C57Bl/6 mice for sixteen weeks. Mice received an antibiotic cocktail containing 0.5g/L of vancomycin, 1.0 g/L ampicillin, 1.0 g/L neomycin, and 1.0 g/L metronidazole in their drinking water during the last six weeks of the study and were compared to control mice receiving normal drinking water throughout the study. We observed a significant reduction in gut microbiome diversity for groups that received the antibiotic cocktail, as determined by Illumina next-generation sequencing. Male mice fed the HF diet (± antibiotics) had significantly greater body weights compared to all other groups. And, female mice fed the low fat (LF) diet and administered antibiotics revealed significantly decreased microgliosis and astrogliosis in the hippocampus compared to LF-fed females without antibiotics. Interestingly, male mice fed the LF diet and administered antibiotics revealed significantly increased microgliosis, but decreased astrogliosis, compared to LF-fed males without antibiotics. The observed sex differences in LF-fed mice given antibiotics brings forward questions about sex differences in nutrient metabolism, gut microbiome composition, and response to antibiotics.
- Open Access
- 19 March 2021
- Published by Wiley in Autism Research and Treatment
- Vol. 2021, 1-10
A Need for Consistency in Behavioral Phenotyping for ASD: Analysis of the Valproic Acid Model
Autism spectrum disorder (ASD) is a highly prevalent and impairing neurodevelopmental disorder that affects 1:54 persons. Over the last several decades, the reported incidence of ASD in the US has increased potentially due to increased awareness and improved diagnostic measurement. Although ASD prevalence is increasing, the etiology of ASD remains relatively unknown. To better understand the neurological basis of ASD, rodent models of ASD have been developed for research. Currently, there is not a standardized set of behavioral tests to quantify ASD-like behavior in rodents. The goal of this review is to present an overview of the methodologies used to analyze ASD-like behaviors in rodents, focusing on the valproic acid (VPA) model, and illustrate inconsistencies between different approaches. Despite that the in utero VPA rodent model for ASD is widely used and extensively characterized, behaviors vary substantially between different researchers. Moving forward, consistency in behavioral method analytics would benefit progress in evaluating interventions for all models of ASD and help to uncover unique qualities underlying mechanisms causing ASD signs and symptoms.
- 19 March 2021
- Published by Wiley in Autism Research and Treatment
- Vol. 2021, 1-10
Open AccessA Need for Consistency in Behavioral Phenotyping for ASD: Analysis of the Valproic Acid Model
Autism spectrum disorder (ASD) is a highly prevalent and impairing neurodevelopmental disorder that affects 1:54 persons. Over the last several decades, the reported incidence of ASD in the US has increased potentially due to increased awareness and improved diagnostic measurement. Although ASD prevalence is increasing, the etiology of ASD remains relatively unknown. To better understand the neurological basis of ASD, rodent models of ASD have been developed for research. Currently, there is not a standardized set of behavioral tests to quantify ASD-like behavior in rodents. The goal of this review is to present an overview of the methodologies used to analyze ASD-like behaviors in rodents, focusing on the valproic acid (VPA) model, and illustrate inconsistencies between different approaches. Despite that the in utero VPA rodent model for ASD is widely used and extensively characterized, behaviors vary substantially between different researchers. Moving forward, consistency in behavioral method analytics would benefit progress in evaluating interventions for all models of ASD and help to uncover unique qualities underlying mechanisms causing ASD signs and symptoms.
- 16 April 2020
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 25  (2) , 321-335
Sex differences in response to a high fat, high sucrose diet in both the gut microbiome and hypothalamic astrocytes and microglia
Objectives: Obesity is a major epidemic in our population and has emerged as a primary health concern. Consumption of a high fat, high sugar (HFHS) diet can specifically lead to gut dysbiosis, increased inflammation, and neuroinflammation. Interestingly, sex differences in the response to a HFHS diet are emerging. In this study, we investigated the effects of a HFHS diet compared to a low fat, low sugar (LFLS) diet in 8 week old male and female C57Bl/6 mice. Methods: The diet was administered for 14 weeks; body weights and food consumption were evaluated weekly. Results: Male and female mice fed the HFHS diet gained significantly more weight than LFLS-fed mice. However, in agreement with previous studies, males gained significantly more weight on the HFHS diet compared to females fed the same diet. Importantly, we determined significant sex and diet-induced differences to gut microbiome composition using next generation Illumina sequencing. We also observed significantly less astrocyte densitometry and no significant change to microglial morphology in the hypothalamus of Female HFHS compared to Female LFLS. On the other hand, Male HFHS revealed no change to hypothalamic astrogliosis, but increased microgliosis compared to Male LFLS. Discussion: In this study, we determined sex and diet-induced differences in both the gut and the brain, however, future studies will need to be performed in order to test the direct role of the gut microbiome to weight gain and neuroinflammation in male and female mice.
- 16 April 2020
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 25  (2) , 321-335
Sex differences in response to a high fat, high sucrose diet in both the gut microbiome and hypothalamic astrocytes and microglia
Objectives: Obesity is a major epidemic in our population and has emerged as a primary health concern. Consumption of a high fat, high sugar (HFHS) diet can specifically lead to gut dysbiosis, increased inflammation, and neuroinflammation. Interestingly, sex differences in the response to a HFHS diet are emerging. In this study, we investigated the effects of a HFHS diet compared to a low fat, low sugar (LFLS) diet in 8 week old male and female C57Bl/6 mice. Methods: The diet was administered for 14 weeks; body weights and food consumption were evaluated weekly. Results: Male and female mice fed the HFHS diet gained significantly more weight than LFLS-fed mice. However, in agreement with previous studies, males gained significantly more weight on the HFHS diet compared to females fed the same diet. Importantly, we determined significant sex and diet-induced differences to gut microbiome composition using next generation Illumina sequencing. We also observed significantly less astrocyte densitometry and no significant change to microglial morphology in the hypothalamus of Female HFHS compared to Female LFLS. On the other hand, Male HFHS revealed no change to hypothalamic astrogliosis, but increased microgliosis compared to Male LFLS. Discussion: In this study, we determined sex and diet-induced differences in both the gut and the brain, however, future studies will need to be performed in order to test the direct role of the gut microbiome to weight gain and neuroinflammation in male and female mice.
- 1 March 2020
- Published by Elsevier in Brain Research
- Vol. 1731, 145928
Activation of medial hypothalamic orexin neurons during a Go/No-Go task
- 1 March 2020
- Published by Elsevier in Brain Research
- Vol. 1731, 145928
Activation of medial hypothalamic orexin neurons during a Go/No-Go task
- Open Access
- 11 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5  (10) , eaax7031
Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal
Nearly 80% of smokers attempting to quit fail, but research on microglia may open a new avenue for smoking cessation drugs.
- 11 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5  (10) , eaax7031
Open AccessMicroglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal
Nearly 80% of smokers attempting to quit fail, but research on microglia may open a new avenue for smoking cessation drugs.
- Open Access
- 29 May 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14  (5) , e0217553
High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats
As the global population ages, and rates of dementia rise, understanding lifestyle factors that play a role in the development and acceleration of cognitive decline is vital to creating therapies and recommendations to improve quality of later life. Obesity has been shown to increase risk for dementia. However, the specific mechanisms for obesity-induced cognitive decline remain unclear. One potential contributor to diet-induced cognitive changes is neuroinflammation. Furthermore, a source of diet-induced inflammation to potentially increase neuroinflammation is via gut dysbiosis. We hypothesized that a high fat diet would cause gut microbe dysbiosis, and subsequently: neuroinflammation and cognitive decline. Using 7-month old male Sprague Dawley rats, this study examined whether 8 weeks on a high fat diet could impact performance on the water radial arm maze, gut microbe diversity and abundance, and microgliosis. We found that a high fat diet altered gut microbe populations compared to a low fat, control diet. However, we did not observe any significant differences between dietary groups on maze performance (a measure of spatial working memory) or microgliosis. Our data reveal a significant change to the gut microbiome without subsequent effects to neuroinflammation (as measured by microglia characterization and counts in the cortex, hippocampus, and hypothalamus) or cognitive performance under the parameters of our study. However, future studies that explore duration of the diet, composition of the diet, age of animal model, and strain of animal model, must be explored.
- 29 May 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14  (5) , e0217553
Open AccessHigh fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats
As the global population ages, and rates of dementia rise, understanding lifestyle factors that play a role in the development and acceleration of cognitive decline is vital to creating therapies and recommendations to improve quality of later life. Obesity has been shown to increase risk for dementia. However, the specific mechanisms for obesity-induced cognitive decline remain unclear. One potential contributor to diet-induced cognitive changes is neuroinflammation. Furthermore, a source of diet-induced inflammation to potentially increase neuroinflammation is via gut dysbiosis. We hypothesized that a high fat diet would cause gut microbe dysbiosis, and subsequently: neuroinflammation and cognitive decline. Using 7-month old male Sprague Dawley rats, this study examined whether 8 weeks on a high fat diet could impact performance on the water radial arm maze, gut microbe diversity and abundance, and microgliosis. We found that a high fat diet altered gut microbe populations compared to a low fat, control diet. However, we did not observe any significant differences between dietary groups on maze performance (a measure of spatial working memory) or microgliosis. Our data reveal a significant change to the gut microbiome without subsequent effects to neuroinflammation (as measured by microglia characterization and counts in the cortex, hippocampus, and hypothalamus) or cognitive performance under the parameters of our study. However, future studies that explore duration of the diet, composition of the diet, age of animal model, and strain of animal model, must be explored.